IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Thyrocare Technologies IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 479.21 Cr. The company is based in Mumbai and caters to Healthcare sector. Edelweiss Financial Services , ICICI Securities , Jm Financial are the merchant bankers of Thyrocare Technologies IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th December 2015.
Thyrocare Technologies IPO posted revenues of ₹ 234.55 Cr. and PAT of ₹ 53.33 Cr. in FY16 on annualised basis.
Revenue:
₹ 234.55 Cr.
EBITDA Margin:
43.32
% 
Net Worth: ₹ 367.42 Cr.
Market Capitalisation:
[●]
P/E:
45.00 times
P/BV: [●]
EV/EBITDA: -0.07 times
Financial results of Thyrocare Technologies IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Dec-15 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 392.85 | 329.56 | 245.73 | 196.53 | |
| Net Worth | 367.42 | 274.21 | 206.26 | 160.10 | |
| Total Debt | [●] | [●] | 25.00 | 25.00 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
175.91
234.55 |
182.95 | 149.97 | 134.26 | |
EBITDA
EBITDA on annualised basis |
76.21
101.61 |
79.18 | 75.25 | 69.18 | |
PAT
PAT on annualised basis |
40.00
53.33 |
44.43 | 46.15 | 56.81 | |
Thyrocare Technologies IPO PAT Margin is 22.74 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Thyrocare Technologies IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Dec-15 | FY15 | FY14 | FY13 |
|---|---|---|---|---|
| EBITDA Margin (%) | 43.32 | 43.28 | 50.18 | 51.53 |
| PAT Margin (%) | 22.74 | 24.29 | 30.77 | 42.31 |
| EPS (₹) | 7.89 | 8.98 | 10.57 | 13.04 |
| ROE (%) | 10.89 | 16.20 | 22.37 | 35.48 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 10.18 | 13.48 | 18.78 | 28.91 |
| Debt to Equity | [●] | [●] | 0.12 | 0.16 |
The market Capitalisation of Thyrocare Technologies IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Thyrocare Technologies IPO prospectus highlights an Return on Equity (ROE) of 10.89 % , Return on Assets (ROA) of 10.18 %, and an EBITDA Margin of 43.32 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Thyrocare Technologies IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Thyrocare Technologies IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Thyrocare Technologies IPO has a Price-to-Earnings (PE) ratio of 45.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Thyrocare Technologies IPO reported revenue of ₹ 240.63 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Thyrocare Technologies IPO provide insights into sales growth, market demand, and business scalability.
Thyrocare Technologies recorded an EBITDA of ₹ 101.61 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Thyrocare Technologies Profit After Tax (PAT) is ₹ 53.33 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 234.55 Cr.
EBITDA Margin:
43.32
%
Net Worth: ₹ 367.42 Cr.
Market Capitalisation:
[●]
P/E:
45.00 times
P/BV: [●]
EV/EBITDA:
[●]
Thyrocare Technologies operates in Healthcare and Diagnostic Chains And Conducts An Array Of Medical Diagnostic Tests And Profiles Of Tests That Center. The Issue is listed on BSE,NSE in May, 2016. Thyrocare Technologies IPO size was 479.21 with Issue price of 446.00 .
Merchant Banker(s) of Thyrocare Technologies IPO: Edelweiss Financial Services Limited , ICICI Securities Limited , Jm Financial Limited
Thyrocare Technologies IPO subscription was 73.55 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Thyrocare Technologies IPO listed at a listing price of 618.10 against the offer price of 446.00.
The current market price of Thyrocare Technologies is 1184.35.
Why Us?
